Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) - Part 2 on Triage, Treatment and Follow-up.
Kwaliteit van de gezondheidszorg
Ziekten en gezondheid in kaart brengen
Downloaden 263.46 KBAuteurs
Hillemanns, Peter [3]; Klaus Friese [4]; Christian Dannecker [5]; Stefanie Klug [6]; Ulrike Seifert [7]; Thomas Iftner [8]; Juliane Hädicke [9]; Thomas Löning [10]; Lars Horn [11]; Dietmar Schmidt [12]; Hans Ikenberg [13]; Manfred Steiner [14]; Ulrich Freitag [15]; Uwe Siebert [16]; Gaby Sroczynski [17]; Willi Sauerbrei [18]; Matthias W Beckmann [19]; Marion Gebhardt [20]; Michael Friedrich [21]; Karsten Münstedt [22]; Schneider, Achim [23]; Kaufmann, Andreas [24]; K Ulrich Petry [25]; Axel P A Schäfer [26]; Pawlita, Michael [27]; Joachim Weis [28]; Anja Mehnert [29]; Mathias Fehr [30]; Christoph Grimm [31]; Olaf Reich [32]; M. Arbyn [33]; Jos Kleijnen [34]; Simone Wesselmann [35]; Monika Nothacker [36]; Markus Follmann [37]; Thomas Langer [38]; Matthias Jentschke [39]Trefwoorden
Samenvatting:
EN
AIMS
Annual opportunistic screening for cervical carcinoma has been done in Germany since 1971. The creation of this S3 guideline meets an important need, outlined in the National Cancer Plan, with regard to screening for cervical cancer, as this guideline aims to provide important information and support for planned organized screening for cervical cancer in Germany.
METHODS
With the financial support of German Cancer Aid, 21 professional societies developed evidence-based statements and recommendations (classified using the GRADE system) for the screening, management and treatm…